Dr. Melissa Aldrich and guest host Karen Ashforth, MS, OTR, CLT-LANA, explored cutting-edge research on imaging and lymphatic dysfunction at the November Research Roundtable. From studying breast cancer patients at high risk for developing lymphedema to investigating the immunological changes that contribute to the condition, Dr. Aldrich shared valuable insights for both clinicians and patients.
Her groundbreaking study on intermittent pneumatic compression (IPC) therapy provided visual proof that this modality promotes lymph movement in stage I, II, and III lymphedema. Her ongoing research also suggests that early use of IPC may benefit those with systemic inflammatory disease.
How does BMI affect lymphedema and its treatment? What role does exercise play? What are cytokines, and how do they influence inflammation and lymphatic health? Dr. Aldrich addressed these questions and more, offering a glimpse into promising, unpublished findings still to come.
Lympha Press played an integral role in Dr. Aldrich’s indocyanine green (ICG) imaging study on the efficacy of pneumatic compression therapy and continues to lead innovation that improves life for people with lymphedema, lipedema, chronic venous insufficiency (CVI), and wounds. Learn more at lymphapress.com.
This Roundtable was originally recorded live on November 3, 2025. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of Lympha Press. The content is for educational purposes only and not intended as medical advice.
Watch more Roundtables from our Lympha Press Research Roundtables playlist on YouTube.
